Microbes inside—from diversity to function: the case of Akkermansia
By C. Belzer, Willem M. de Vos. The ISME Journal, 2012
647 citations recorded by the source corpus.
Subfields: Food Science, Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/a3a2dc78e6b27c95d416f9ffb89cf37e7cc339da
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Food Science
In Genetics
In Molecular Biology
Citations in the corpus
- Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila (2017, background): “…muciniphila was decreased in several pathological situations such as obesity, type 2 diabetes, inflammatory bowel diseases, hypertension and liver diseases (Png et al., 2010; Belzer and de Vos, 2012; Zhang et al., 2013; Dao et al., 2015; Yassour et al., 2016; Grander et al., 2017; Li et al., 2017).”
- Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity (2013, background): “muciniphilamay represent 3–5% of the microbial community (18, 19) in healthy subjects, and its abundance inversely correlates with body weight (20–23) and type 1 diabetes (24) in mice and humans, although a recent metagenomic study found that some of the genes belonging toA.”
- The Rebirth of Culture in Microbiology through the Example of Culturomics To Study Human Gut Microbiota (2015, background): “whipplei infection was acquired only after the first culture (122, 162).”
- A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice (2014, background): “Singletons (OTUs with a unique sequence occurring only once among all reads) were discarded at this step.”
- Akkermansia muciniphila is a promising probiotic (2019, background): “Due to this unique function and its high universality and richness in almost all life stages, A. muciniphila has opened new avenues for the application in next-generation therapeutic probiotics (Collado et al., 2007; Derrien et al., 2008; Belzer and de Vos, 2012; Cani and de Vos, 2017).”
- The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota (2017, background): “muciniphila may ferment HMOs (450) make this species a relevant inhabitant in the early-life gut, even at low abundance, and a potential target for therapeutic developments aimed at increasing barrier function (451, 452).”